At the news
? NEUTRALIMPACT 2/10 SC 13G/A filed Nov 5, 2026 at 13:24 ET
FMR LLC (Fidelity) filed an amended Schedule 13G disclosing a 4.3% passive stake in Royalty Pharma plc as of September 30, 2026, down from prior filings. The filing is routine and reflects a reduction in Fidelity's holdings, but the stake remains below the 5% threshold, indicating continued passive ownership without activist intent.
- FMR LLC reported beneficial ownership of 19,288,880.43 shares of Royalty Pharma Class A common stock as of September 30, 2026.
- The stake represents 4.3% of shares outstanding, down from prior filings where the stake was above 5%.
- Fidelity filed as a passive investor under Rule 13d-1(b), certifying shares were not acquired to influence control.
- The filing is an amendment to a Schedule 13G, not a 13D, confirming no activist intent.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access